Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases

NCT02688686 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non-Small-Cell Lung Cancer With Bone Metastases

Interventions

BIOLOGICAL: genetically modified dendritic cells + cytokine-induced killer

Sponsor

Affiliated Hospital to Academy of Military Medical Sciences